The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Anxiety caused by a short-life hypnotic.
Open accessAbstract
A comprehensive understanding of the changes in gene expression in cell types involved in idiopathic pulmonary fibrosis (IPF) will shed light on the mechanisms underlying the loss of alveolar epithelial cells, and development of honeycomb cysts and fibroblastic foci. We sought to understand changes in IPF lung cell transcriptomes and gain insight into innate immune aspects of pathogenesis. We investigated IPF pathogenesis using single cell RNA-sequencing of fresh lung explants, comparing human IPF fibrotic lower lobes reflecting late disease, upper lobes reflecting early disease and normal lungs. IPF lower lobes showed increased fibroblasts, and basal, ciliated, goblet and club cells, but decreased alveolar epithelial cells, and marked alterations in inflammatory cells. We found three discrete macrophage subpopulations in normal and fibrotic lungs, one expressing monocyte markers, one highly expressing FABP4 and INHBA (FABP4hi), and one highly expressing SPP1 and MERTK (SPP1hi). SPP1hi macrophages in fibrotic lower lobes showed highly upregulated SPP1 and MERTK expression. Low-level local proliferation of SPP1hi macrophages in normal lungs was strikingly increased in IPF lungs. Co-localisation and causal modelling supported the role for these highly proliferative SPP1hi macrophages in activation of IPF myofibroblasts in lung fibrosis. These data suggest SPP1hi macrophages contribute importantly to lung fibrosis in IPF, and that therapeutic strategies targeting MERTK and macrophage proliferation may show promise for treatment of this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These symptoms are more severe following withdrawal from short rather than long half-life BZDs [39,40,41,42,43].”
From Cognitive behavioral therapy and acceptance and commitment therapy for the discontinuation of long-term benzodiazepine use in insomnia and anxiety disorders (2021) · cites this paper as [40]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The prevalence of rebound insomnia was found to be significantly lower in all benzodiazepines compared to triazolam [52, 60-69] and was lower than that with triazolam.”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [63]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dexamethasone Proves Deleterious in Cerebral Malaria
Warrell, D. A., Looareesuwan, S., Warrell, M. J., Kasemsarn, P., Intaraprasert, R., BUNNAG, D., & Harinasuta, T. (1982) · New England Journal of Medicine · doi:10.1056/nejm198202113060601 · Cited by 485
Withdrawal from long-term benzodiazepine treatment
Petursson, H., & Lader, M. H. (1981) · BMJ · doi:10.1136/bmj.283.6292.643 · Cited by 367
van der Kroef, C. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91578-2 · Cited by 95
Anxiety and sleep after fosazepam.
Allen, S., & Oswald, I. (1976) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1976.tb00584.x · Cited by 43
Self-citationTwo Anti-anxiety Drugs: A Psychoneuroendocrine Study
Ogunremi, O. O., Adamson, L., Březinová, V., Hunter, W. M., Maclean, A. W., Oswald, I., & PERCY-ROBB, I. W. (1973) · BMJ · doi:10.1136/bmj.2.5860.202 · Cited by 41
Self-citation
Cited by
Sorted by citations
Jerram, T. C. (1981) · Side effects of drugs annual · doi:10.1016/s0378-6080(81)80009-8 · Cited by 695
Meta-analysis of benzodiazepine use in the treatment of insomnia.
(2000) · PubMed Central · Cited by 613
Guidelines for the Rational Use of Benzodiazepines: When and What to Use
Ashton, H. (1994) · Drugs · doi:10.2165/00003495-199448010-00004 · Cited by 593
Midazolam A Review of its Pharmacological Properties and Therapeutic Use
DUNDEE, J. W., Halliday, N. J., Harper, K. W., & Brogden, R. N. (1984) · Drugs · doi:10.2165/00003495-198428060-00002 · Cited by 357
Benzodiazepine Dependence A Review of the Evidence
Owen, R. T., & Tyrer, P. J. (1983) · Drugs · doi:10.2165/00003495-198325040-00003 · Cited by 287
Gradual Withdrawal of Diazepam after Long-Term Therapy
Tyrer, P., Owen, R., & Dawling, S. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92355-3 · Cited by 271
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Sensitivity to triazolam in the elderly
Greenblatt, D. J., Harmatz, J. S., Shapiro, L., Engelhardt, N., Gouthro, T. A., & Shader, R. I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106133242403 · Cited by 258
Use and Abuse of the Benzodiazepines
Fraser, A. D. (1998) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199810000-00007 · Cited by 243
Kanto, J. (1985) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1985.tb03411.x · Cited by 238
Prevalence, frequency, and duration of hypnotic drug use among the elderly living at home
Morgan, K., Dallosso, H. M., Ebrahim, S. B. J., Arie, T., & Fentem, P. H. (1988) · BMJ · doi:10.1136/bmj.296.6622.601 · Cited by 206
Self-citationWoods, J. H., & Winger, G. D. (1995) · Psychopharmacology · doi:10.1007/bf02245824 · Cited by 195
Quazepam: Hypnotic Efficacy and Side Effects
Kales, A. (1990) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1990.tb02545.x · Cited by 188
Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.7.848 · Cited by 176
Delirium in hospitalized elderly
Francis, J., & Kapoor, W. N. (1990) · Journal of General Internal Medicine · doi:10.1007/bf02602312 · Cited by 139
Early Morning Insomnia with Rapidly Eliminated Benzodiazepines
Kales, A., Soldatos, C. R., Bixler, E. O., & Kales, J. D. (1983) · Science · doi:10.1126/science.6131538 · Cited by 138
The pharmacology of human anxiety
Nutt, D. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90089-k · Cited by 114
Precipitated diazepam withdrawal in baboons: Effects of dose and duration of diazepam exposure
Lukas, S. E., & Griffiths, R. R. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90218-8 · Cited by 97
Rational Use of Benzodiazepines in the Elderly
Shorr, R. I., & Robin, D. W. (1994) · Drugs & Aging · doi:10.2165/00002512-199404010-00002 · Cited by 92
Pharmacokinetic Determinants of Dynamic Differences Among Three Benzodiazepine Hypnotics
Greenblatt, D. J. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810040032006 · Cited by 79
Sleep Disorders: Insomnia, Sleepwalking, Night Terrors, Nightmares, and Enuresis
Kales, A., SOLDATOS, C. R., & KALES, J. D. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-4-582 · Cited by 77
Benzodiazepines and caffeine: effect on daytime sleepiness, performance, and mood
Johnson, L. C., Spinweber, C. L., & Gomez, S. A. (1990) · Psychopharmacology · doi:10.1007/bf02244120 · Cited by 75
Morgan, K. (1990) · Drugs · doi:10.2165/00003495-199040050-00004 · Cited by 70
Self-citationRelative abuse liability of triazolam: Experimental assessment in animals and humans
Griffiths, R. R., Lamb, R. J., Ator, N. A., Roache, J. D., & Brady, J. V. (1985) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(85)90039-9 · Cited by 70
Effects of loprazolam and of triazolam on sleep and overnight urinary cortisol
Adam, K., Oswald, I., & Shapiro, C. M. (1984) · Psychopharmacology · doi:10.1007/bf00427692 · Cited by 68
Self-citationChapoutot, M., Peter-Derex, L., Bastuji, H., Leslie, W., Schoendorff, B., Heinzer, R., Siclari, F., Nicolas, A., Lemoine, P., Higgins, S., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph181910222 · Cited by 59
The biological basis of benzodiazepine dependence
LADER, M. H., & File, S. E. (1987) · Psychological Medicine · doi:10.1017/s0033291700025794 · Cited by 60
Watson, N. F., Benca, R. M., Krystal, A. D., McCall, W. V., & Neubauer, D. N. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072493 · Cited by 59
Tyrer, P. J. (1984) · BMJ · doi:10.1136/bmj.288.6424.1101 · Cited by 58
Management of Insomnia in Hospitalized Patients
Berlin, R. M. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-3-398 · Cited by 55
Neurochemical and pharmacokinetic correlates of the clinical action of benzodiazepine hypnotic drugs
Greenblatt, D. J., Miller, L. G., & Shader, R. I. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90281-h · Cited by 51
Dependence as a limiting factor in the clinical use of minor tranquillizers
Tyrer, P. J. (1988) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(88)90105-2 · Cited by 51
Pharmacology and Hypnotic Efficacy of Triazolam
Roth, T. G., Roehrs, T., & Zorick, F. J. (1983) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1983.tb03237.x · Cited by 48
Hypnotics and sleep physiology: A consensus repot
Borbély, A. A., Åkerstedt, T., Benoit, O., Holsboer, F., & Oswald, I. (1991) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02193749 · Cited by 46
Self-citationAlprazolam: Effects on Sleep and Withdrawal Phenomena
Kales, A., Bixler, E. O., Vela‐Bueno, A., Soldatos, C. R., & Manfredi, R. L. (1987) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1987.tb03058.x · Cited by 46
Mamelak, M., Csima, A., & Price, V. (1984) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1984.tb02767.x · Cited by 45
Single dose pharmacokinetics and pharmacodynamics of oral loprazolam in the elderly.
Swift, C. G., Swift, M., Ankier, S., Pidgen, A. W., & Robinson, J. (1985) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1985.tb05041.x · Cited by 43
TRIAZOLAM SYNDROME 10 YEARS ON
Oswald, I. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90630-2 · Cited by 38
Self-citationThe natural history of tolerance to the benzodiazepines
Higgitt, A., Fonagy, P., & Lader, M. (1988) · Psychological Medicine. Monograph Supplement · doi:10.1017/s0264180100000412 · Cited by 37
A double‐blind controlled study of chlormethiazole and triazolam as hypnotics in the elderly
Bayer, A. J., Bayer, E. M., Pathy, M., & Stoker, M. J. (1986) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1986.tb10544.x · Cited by 33
Anxiety or depression during withdrawal of hypnotic treatments
LADER, M. H. (1994) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(94)90142-2 · Cited by 30
Midazolam‐induced benzodiazepine withdrawal syndrome
Mets, B., HORSELL, A., & Linton, D. M. (1991) · Anaesthesia · doi:10.1111/j.1365-2044.1991.tb09309.x · Cited by 29
Abraham, J. M. (2002) · Social Science & Medicine · doi:10.1016/s0277-9536(02)00160-0 · Cited by 28
O’Donovan, M. C., & McGuffin, P. (1993) · BMJ · doi:10.1136/bmj.306.6883.945 · Cited by 25
A Guide to Benzodiazepine Selection. Part II: Clinical Aspects
Teboul, E., & Chouinard, G. (1991) · The Canadian Journal of Psychiatry · doi:10.1177/070674379103600117 · Cited by 25
Early morning insomnia, daytime anxiety, and organic mental disorder associated with triazolam.
Tan, T. L., Bixler, E. O., Kales, A., Cadieux, R. J., & Goodman, A. L. (1985) · PubMed · Cited by 25
Clow, A., Glover, V. A. S., & Sandler, M. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb04031.x · Cited by 25
Treatment of benzodiazepine dependence
Lennane, K. J. (1986) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1986.tb112319.x · Cited by 23
Pharmacokinetics of benzodiazepines: metabolic pathways and plasma level profiles
Jochemsen, R., & Breimer, D. D. (1984) · Current Medical Research and Opinion · doi:10.1185/03007998409109545 · Cited by 22
Lau, C. E., & Heatherington, A. C. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37120-4 · Cited by 22
Mendelson, W. B. (1987) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30533-1 · Cited by 22
Benzodiazepine Hypnotics and Insomnia
Kales, A. (1990) · Hospital Practice · doi:10.1080/21548331.1990.11704103 · Cited by 22
Behavioral Side Effects of Triazolam in Psychiatric Inpatients: Report of Five Cases
Soldatos, C. R., Sakkas, P. N., Bergiannaki, J. D., & Stefanis, C. N. (1986) · Annals of Pharmacotherapy · doi:10.1177/106002808602000418 · Cited by 22
Clinical Comparison of Benzodiazepine Hypnotics With Short and Long Elimination Half-Lives
Kales, A., Soldatos, C. R., & Vela‐Bueno, A. (1985) · Springer eBooks · doi:10.1007/978-94-009-4886-0_9 · Cited by 20
Jochemsen, R., van Rijn, P. A., Hazelzet, T. G. M., van Boxtel, C. J., & Breimer, D. D. (1986) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510070108 · Cited by 19
Billiard, M. M., Besset, A., de Lustrac, C., Brissaud, L., & Cadilhac, J. (1989) · Neurophysiologie Clinique · doi:10.1016/s0987-7053(89)80053-x · Cited by 19
Brotizolam: A sleep laboratory evaluation
Vela‐Bueno, A., Oliveros, J. R. G., Dobladez-Blanco, B., Arrigain-Ijurra, S., Soldatos, C. R., & Kales, A. (1983) · European Journal of Clinical Pharmacology · doi:10.1007/bf00544014 · Cited by 19
A comparison of oral midazolam, nitrazepam and placebo in young and elderly subjects
Castleden, C. M., Allen, J. G., Altman, J. F. B., & John-Smith, P. S. (1987) · European Journal of Clinical Pharmacology · doi:10.1007/bf00607572 · Cited by 18
Hockings, N., & Ballinger, B. R. (1983) · BMJ · doi:10.1136/bmj.286.6382.1949 · Cited by 18
The clinical use of hypnotics: indications for use and the need for a variety of hypnotics
Rickels, K. (1986) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1986.tb08990.x · Cited by 16
Effects of loprazolam and of triazolam on psychological functions
Morgan, K., Adam, K., & Oswald, I. (1984) · Psychopharmacology · doi:10.1007/bf00427691 · Cited by 16
Self-citationEffects of lormetazepam and of flurazepam on sleep.
Adám, K., & Oswald, I. (1984) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1984.tb02386.x · Cited by 16
Self-citationDrug Treatment of Patients with Insomnia and Excessive Daytime Sleepiness
Nishino, S., & Mignot, E. J.-M. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937040-00003 · Cited by 15
Triazolam and Temazepam: Issues and Concerns Relevant to the Army Aviation Community
Caldwell, J. L., Comperatore, C. A., & Shanahan, D. F. (1992) · Defense Technical Information Center (DTIC) · Cited by 13
Triazolam—An “Abused Drug” by the Lay Press?
Schneider, P. J., & Perry, P. J. (1990) · DICP · doi:10.1177/106002809002400410 · Cited by 13
Alcohol and benzodiazepines generate anxiety, panic and phobias.
Cohen, S. I. (1995) · Europe PMC (PubMed Central) · Cited by 12
Moon, C. A. L., Ankier, S. I., & Hayes, G. R. (1985) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1985.tb07857.x · Cited by 12
McInnes, G. T., BUNTING, E. A., Ings, R., Robinson, J., & Ankier, S. (1985) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1985.tb02692.x · Cited by 12
Regulatory Science As Culture: Contested Two-dimensional Values at the US FDA
Abraham, J. M. (2002) · Science as Culture · doi:10.1080/0950543022000005069 · Cited by 11
Benzodiazepine dependence potential: Current studies and trends
Smith, D. E. (1984) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(84)90019-9 · Cited by 11
Kubicki, S., Haag‐Wüsthof, C., Röhmel, J., Herrmann, W. M., & Scheuler, W. (1988) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470030404 · Cited by 11
Bixler, E. O., Kales, A., Manfredi, R. L., & Vgontzas, A. N. (1991) · The Lancet · doi:10.1016/0140-6736(91)92266-5 · Cited by 11
Tranquilizer und Hypnotika: Grundlagen und Therapie
Haefely, W. E., Pöldinger, W., & Wider, F. (1983) · Springer eBooks · doi:10.1007/978-3-7091-7645-0_7 · Cited by 10
Oswald, I. (1991) · The Lancet · doi:10.1016/0140-6736(91)90592-d · Cited by 10
Self-citationCorrelation of the clinical pharmacodynamics of loprazolam with serum concentration
Stevens, L. A., Pidgen, A. W., Bevan, C. D., Ings, R. M. J., LAWRENCE, J. R., & McEwen, J. (1985) · Xenobiotica · doi:10.3109/00498258509045892 · Cited by 9
Methodological Issues in Pharmacological Studies of Sleep
Bixler, E. O., Vgontzas, A. N., & Kales, A. (1995) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57836-6_12 · Cited by 9
Insomnia as a Problem for the Elderly
Engle‐Friedman, M., & Bootzin, R. R. (1991) · Springer eBooks · doi:10.1007/978-1-4899-0638-0_12 · Cited by 8
Recent advances in the clinical pharmacology of benzodiazepines part I: Pharmacokinetics
Saletu, B., & Pakesch, G. (1987) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470020103 · Cited by 8
A review of the utilization of sedative-hypnotic drugs in a general hospital
Picone, D. A., D’Mello, D. A., Foote, M. L., & Msibi, B. (1993) · General Hospital Psychiatry · doi:10.1016/0163-8343(93)90091-2 · Cited by 8
Dépendance aux benzodiazépines et syndrome de sevrage. Revue de la littérature
Hanin, B., & Marks, J. (1988) · Psychiatry and Psychobiology · doi:10.1017/s0767399x00002480 · Cited by 7
The Triazolam Experience in 1979 in The Netherlands, a Problem of Signal Generation and Verification
Meyboom, R. H. B. (1992) · Springer eBooks · doi:10.1007/978-1-4899-2587-9_19 · Cited by 7
Riedel, W. J., Quasten, R., Hausen, C., O’Hanlon, J. F., & Leiden University (2007) · ROSA P · doi:10.21949/1524989 · Cited by 7
Abuse and Dependency:An International Perspective
Smith, D. E., & Marks, J. (1985) · Springer eBooks · doi:10.1007/978-94-009-4886-0_14 · Cited by 7
Fleming, J. A. (1983) · PubMed Central · Cited by 7
Pharmacokinetic and Clinical Studies with a Benzodiazepine Radioreceptor Assay
Dorow, R. (1984) · Psychopharmacology series · doi:10.1007/978-3-642-69659-6_10 · Cited by 6
Triazolam. Unpublished manufacturers research unfavourable.
Adám, K., & Oswald, I. (1993) · BMJ · doi:10.1136/bmj.306.6890.1475-b · Cited by 6
Self-citationSpecial problems relating to the use of hypnotics in the elderly
Swift, C. G. (1986) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1986.tb10542.x · Cited by 6
Recent advances in the clinical pharmacology of benzodiazepines part II: Pharmacodynamics
Saletu, B., & Pakesch, G. (1987) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470020203 · Cited by 6
Die Beeinflussung des Schlafs durch Hypnotika
Borbély, A. A. (1992) · Springer eBooks · doi:10.1007/978-3-642-75733-4_4 · Cited by 5
Treatment of triazolam dependence with a tapering withdrawal regimen.
Singh, A. N., Chemij, M., & Jewell, J. S. (1986) · Europe PMC (PubMed Central) · Cited by 5
Daytime consumption of triazolam
Martínez-Cano, H., & Vela‐Bueno, A. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03458.x · Cited by 5
Vuori, E., & Klaukka, T. (1992) · The Lancet · doi:10.1016/0140-6736(92)90832-n · Cited by 5
Hajak, G., Herrendorf, G., & Rüther, E. (1993) · Springer eBooks · doi:10.1007/978-3-642-77111-8_13 · Cited by 5
Loprazolam: An Intermediate Acting Benzodiazepine. A Review Article
Beaumont, G. (1983) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1983.tb11980.x · Cited by 5
Bénéfices et inconvénients des hypnotiques
Benoit, O. (1991) · Neurophysiologie Clinique · doi:10.1016/s0987-7053(05)80374-0 · Cited by 4
Pharmacotherapy for anxiety disorders: using the available drugs
Tyrer, P. J. (1997) · Advances in Psychiatric Treatment · doi:10.1192/apt.3.2.72 · Cited by 4
(1991) · New England Journal of Medicine · doi:10.1056/nejm199112123252412 · Cited by 4
The Treatment of Sleep Disorders
Cook, P. J. (1984) · Springer eBooks · doi:10.1007/978-1-4613-2791-2_7 · Cited by 3
Sleep Disturbances as Side Effects of Therapeutic Drugs
Kales, A., & Vgontzas, A. N. (1995) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57836-6_20 · Cited by 3
Rational Use of Sedative/Hypnotics
Rogers, K. L. (1987) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(21)01046-0 · Cited by 3
Metadata
- Authors
- Morgan, K., & Oswald, I.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1982-03-27
- Volume
- 284
- Issue
- 6320
- Pages
- 942-942
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2150408288
- Cited by
- 137
- References
- 5
- Citations by year
- 2023: 1 · 2021: 1 · 2020: 1 · 2016: 1 · 2013: 1
- FWCI
- 26.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- BMJ (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Keywords
- idiopathic pulmonary fibrosis, pulmonary fibrosis, MERTK, macrophage proliferation, myofibroblast activation, alveolar epithelial cells, macrophage subpopulations, innate immunity, gene expression, single-cell transcriptomics, honeycomb cysts
- MeSH terms
- Anxiety Disorders, Benzodiazepines, Benzodiazepinones, Clinical Trials as Topic, Double-Blind Method, Female, Half-Life, Humans, Male, Middle Aged, Substance Withdrawal Syndrome, Anti-Anxiety Agents, Triazolam
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
